Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
Maemondo M; Inoue A; Kobayashi K; Sugawara S; Oizumi S; Isobe H; Gemma A; Harada M; Yoshizawa H; Kinoshita I; Fujita Y; Okinaga S; Hirano H; Yoshimori K; Harada T; Ogura T; Ando M; Miyazawa H; Tanaka T; Saijo Y; Hagiwara K; Morita S; Nukiwa T; The New England Journal Of Medicine, 2010, vol. 362, issue 25, p 2380, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation